Pictet Asset Management (UK)’s NxStage Medical Inc. NXTM Stock Holding History

Pictet Asset Management (UK)’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-788,232	Closed	-$22.6K	–	1026
2018 Q4	$22.6K	Buy	788,232 +549,908	+231%	+$15.6M	0.06%	343
2018 Q3	$6.65M	Buy	238,324 +33,340	+16%	+$938K	0.01%	666
2018 Q2	$5.72M	Buy	204,984 +197,168	+2,523%	+$5.29M	0.01%	639
2018 Q1	$194K	Buy	+7,816	New	+$190K	﹤0.01%	869

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Pictet Asset Management (UK)'s NXTM Position: Q1 2019 in Review

Pictet Asset Management (UK) sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 788,232 shares — an estimated $22.6K sold.

Pictet Asset Management (UK) first reported a position in NXTM in Q1 2018 and held it in 4 quarters. The position peaked at $6.65M in Q3 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Pictet Asset Management (UK) reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Pictet Asset Management (UK) sold 788,232 NxStage Medical Inc. shares in Q1 2019, an estimated $22.6K.
Pictet Asset Management (UK) first reported a position in NxStage Medical Inc. in Q1 2018 and held it in 4 quarters.
Pictet Asset Management (UK)'s NxStage Medical Inc. position peaked at $6.65M in Q3 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2019, filed 10 May 2019.